COMPANIES AMENDMENT REGULATION
For information only: Made by the Lieutenant Governor in Council (O.C. 144/2021)
on May 27, 2021 pursuant to sections 160 and 307 of the Companies Act.
1 The Companies Regulation (AR 119/2000) is amended by
this Regulation.
2 Section 6 is amended
(a) by repealing subsection (1) and substituting the
following:
Information circular for solicitation of proxies
6(1) An information circular for the purposes of Part 6,
Division 9 of the Act must contain the following information:
(a) whether a person giving a proxy has the power to
revoke it and a brief description of any right of
revocation that is limited or is subject to compliance
with any formal procedure;
(b) the name of the person or persons a solicitation of
proxies is made by or on behalf of, whether it be the
management of the company or another person;
(c) the name of any director who intends to oppose any
action to be taken by the management of the company
and a brief statement of reasons for their opposition;
(d) the method of solicitation;
(e) if the solicitation is to be made by specially engaged
employees or soliciting agents,
(i) the material features of any contract or
arrangement for the solicitation,
(ii) the parties to the contract or arrangement, and
(iii) the cost or anticipated cost of the solicitation;
(f) the name of the person by whom the cost of soliciting
has been or will be borne, directly or indirectly;
(g) the brief particulars of any material interest, direct or
indirect, by way of beneficial ownership of capital
securities or otherwise, of each of the following persons
in any matter to be acted on, other than the election of
directors or the appointment of auditors:
(i) if the solicitation is made by or on behalf of the
management of the company, each person who has
been a director or senior officer of the company at
any time since the beginning of the last completed
financial year of the company;
(ii) if the solicitation is made otherwise than by or on
behalf of the management of the company, each
person on whose behalf, directly or indirectly, the
solicitation is made;
(iii) each proposed nominee for election as a director of
the company;
(iv) each associate of any of the foregoing persons;
(h) the number of shares outstanding of each class of equity
shares of the company entitled to be voted at the
meeting and the number of votes to which each share of
each such class is entitled;
(i) the record date when the shareholders entitled to vote at
the meeting will be determined or particulars of the
closing of the share transfer register, as the case may be,
and, if the right to vote is not limited to shareholders of
record on a specified record date, the conditions under
which shareholders are entitled to vote;
(j) if action is to be taken with respect to the election of
directors and if the shareholders or any class of
shareholders have the right to elect a specified number
of directors or have cumulative or similar voting rights,
a statement of those rights and a brief statement of the
conditions precedent, if any, to the exercise of them;
(k) if, to the knowledge of the directors or senior officers of
the company, any person beneficially owns, directly or
indirectly, equity shares carrying more than 10% of the
voting rights attached to all equity shares of the
company, the name of each such person, the
approximate number of such shares beneficially owned,
directly or indirectly, by each such person and the
percentage of outstanding equity shares of the company
represented by the number of shares so owned;
(l) if directors are to be elected, with respect to each person
proposed to be nominated for election as a director and
each other person whose term of office as a director will
continue after the meeting, a statement that includes the
following:
(i) the name of the person;
(ii) whether the person is a proposed nominee as
director or is a person whose term of office will
continue;
(iii) when the term of office of the director or the term
of office for which that person is a proposed
nominee will expire and all other positions and
offices with the company presently held by that
person;
(iv) the present principal occupation or employment,
the name and principal business of any company or
other organization in which such employment is
carried on and similar information in respect of all
of the principal occupations or employments
within the 5 preceding years of the person, unless
the person is now a director and was elected to the
present term of office by a vote of shareholders at
a meeting, the notice of which was accompanied
by an information circular;
(v) the period or periods during which the person has
served as a director of the company;
(vi) the approximate number of shares of each class of
equity shares of the company or of a subsidiary of
the company beneficially owned, directly or
indirectly, by the person;
(vii) if more than 10% of the voting rights attached to
all equity shares of the company or of a subsidiary
of the company are beneficially owned, directly or
indirectly, by the person and that person's
associates, the approximate number of each class
of such shares beneficially owned by that person
and those associates and the name of each
associate whose shareholdings are substantial;
(m) if any proposed nominee for election as a director is to
be elected pursuant to any arrangement or
understanding between the nominee and any other
person, except the directors and senior officers of the
company acting solely in that capacity, the name of that
other person and a brief description of the arrangement
or understanding;
(n) if action is to be taken with respect to the election of
directors, a bonus, profit sharing, remuneration plan,
contract, arrangement, pension or retirement plan in
which any director or proposed nominee for election as
director or senior officer of the company will
participate, or the granting or extension to any such
person or any options, warrants or rights to purchase
shares or convertible securities,
(i) the aggregate direct remuneration paid or payable
by the company and its subsidiaries whose
financial statements are consolidated with those of
the company to the directors and the senior officers
of the company, during the company's last
completed financial year and, as a separate
amount, the aggregate direct remuneration paid or
payable to those directors and senior officers by
the subsidiaries of the company whose financial
statements are not consolidated with those of the
company,
(ii) the estimated aggregate cost to the company and
its subsidiaries in the last completed financial year
of all pension benefits proposed to be paid, directly
or indirectly, by the company or any of its
subsidiaries to the directors and senior officers
under any normal pension plan in the event of
retirement at normal retirement age or, in the
alternative, the estimated aggregate amount of all
such pension benefits proposed to be paid, directly
or indirectly, by the company or any of its
subsidiaries in the event of retirement at normal
retirement age,
(iii) the aggregate of all other remuneration payments
made during the company's last completed
financial year and, as a separate amount, proposed
to be made in the future, directly or indirectly, by
the company or any of its subsidiaries pursuant to
any existing plan or arrangement to each director
or senior officer, excluding payments to be made
for, or benefits to be received from, group life or
accident insurance, group hospitalization or similar
group benefits or payments,
(iv) for any options to purchase capital securities of the
company or any of its subsidiaries that, since the
commencement of the company's last completed
financial year, were granted to or exercised by
directors or senior officials as a group, without
naming them,
(A) for options granted,
(I) the description and number of capital
securities included,
(II) the dates of the grant, the prices,
expiration dates and other material
provisions,
(III) the consideration received for the
granting of the options, and
(IV) where reasonably ascertainable, in a
summary the price range of the capital
securities in the 30-day period preceding
the date of the grant and, if not
reasonably ascertainable, a statement to
that effect,
and
(B) for options exercised,
(I) the description and number of capital
securities purchased,
(II) the purchase price, and
(III) where reasonably ascertainable, in a
summary the price range of the capital
securities in the 30-day period preceding
the date of purchase and, if not
reasonably ascertainable, a statement to
that effect,
and
(v) in regard to
(A) each director and each senior officer of the
company,
(B) each proposed nominee for election as a
director of the company, and
(C) each associate of any such director, senior
officer or proposed nominee
who is or has been indebted to the company or its
subsidiaries at any time since the beginning of the
last completed financial year of the company, the
largest aggregate amount of indebtedness
outstanding at any time during the period, the
nature of the indebtedness and of the transaction in
which it was incurred, the amount of indebtedness
presently outstanding and the rate of interest paid
or charged on the indebtedness;
(o) a brief description and approximate amount of any
material interest, direct or indirect, of any of the
following persons in any transaction since the
commencement of the company's last completed
financial year or in any proposed transaction that, in
either case, has materially affected or will materially
affect the company or any of its subsidiaries:
(i) any director or senior officer of the company;
(ii) any proposed nominee for election as a director of
the company;
(iii) any shareholder named in answer to clause (k);
(iv) any associate or affiliate of any of the persons
named in answer to subclauses (i) to (iii);
(p) if action is to be taken with respect to the appointment
of auditors, name such auditors and, if appointed within
the preceding 5 years, the date when they were first
appointed;
(q) where management functions of the company or a
subsidiary are to any substantial degree performed by a
person other than the directors or senior officers of the
company or subsidiary,
(i) details of the agreement or arrangement under
which those functions are so performed, including
the name and address of any person who is a party
to the agreement or arrangement or who is
responsible for performing those functions,
(ii) the name and address of each insider of any
company with which the company or subsidiary
has any such agreement or arrangement,
(iii) with respect to any person named in answer to
subclause (i), the amounts paid or payable by the
company and its subsidiaries to that person since
the commencement of the company's last
completed financial year and particulars with
respect to the payments, and
(iv) with respect to any person named in answer to
subclause (i) or (ii) or their associates or affiliates,
(A) any indebtedness of the person to the
company or its subsidiaries that was
outstanding, and
(B) any transaction or arrangement of the person
with the company or subsidiary,
at any time since the commencement of the
company's last completed financial year;
(r) unless otherwise described above, if action is to be
taken on any matter to be submitted to the meeting of
shareholders, other than the approval of financial
statements, a brief description of the substance of each
such matter, or related groups of matters, in sufficient
detail to permit shareholders to form a reasoned
judgment concerning the matter.
(b) in subsection (2) by striking out "called for in Form 1"
and substituting "referred to in subsection (1)".
3 Sections 7 and 9 are repealed.
4 Section 10 is amended
(a) by renumbering it as section 10(1);
(b) in subsection (1) by striking out "must be in Form 4 in
Schedule 1 and" and substituting "must comply with
subsection (2) and";
(c) by adding the following after subsection (1):
(2) The notice referred to in subsection (1) must contain the
following information:
(a) the names of the transferor company, the transferee
company and the dissenting shareholder to whom notice
is being given;
(b) a brief description of the offer and, if the offer is limited
to a certain class or classes of shareholders, the
particulars of the shares;
(c) a brief description of the consequences of the offer and
next steps;
(d) any applicable dates and timelines;
(e) the signature of the authorized representative of the
transferee company.
5 Section 11 is repealed.
6 The following is added before section 15:
Expiry
14.1 For the purpose of ensuring that this Regulation is reviewed
for ongoing relevancy and necessity, with the option that it may be
repassed in its present or an amended form following a review, this
Regulation expires on October 31, 2025.
7 Schedule 1 is repealed.
8 This Regulation comes into force on the coming into
force of section 2(135)(a) of the Red Tape Reduction
Implementation Act, 2020.